5fu-Leucovorin (5fu/Lv) With Or Without Irinotecan (Cpt-Ii) In Stages Ii-Iii Rectal Cancers: Preliminary Safety Analysis Of The French Intergroup R98 Phase Iii Trial.
JOURNAL OF CLINICAL ONCOLOGY（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要